Skip to content

Clinical trials

Adenocarcinoma of Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Country / region: United States Clear all

205 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20019
200210
20033
200412
200511
200612
200712
20089
20097
20104
20119
20127
20135
20148
20153
20164
20178
20181
20195
20207
20213
20228
20238
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed120
Terminated40
Recruiting16
Active, not recruiting15
Withdrawn8
Unknown status5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology27
National Cancer Institute (NCI)24
SWOG Cancer Research Network15
Radiation Therapy Oncology Group9
Memorial Sloan Kettering Cancer Center7
Roswell Park Cancer Institute7
Novartis Pharmaceuticals6
Wake Forest University Health Sciences6
Jonsson Comprehensive Cancer Center4
M.D. Anderson Cancer Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung205
Carcinoma, Non-Small-Cell Lung162
Lung Neoplasms142
Adenocarcinoma, Bronchiolo-Alveolar67
Pancreatic Neoplasms12
Ovarian Neoplasms11
Breast Neoplasms10
Colorectal Neoplasms10
Neoplasms10
Neoplasm Metastasis9

Trials

Showing 1 to 25 of 205. Each trial links to its page on Pharma Observatory.

105 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.